Healthcare Technology Report August 21, 2024

Roche has effectively acquired LumiraDx’s Point of Care technology, having obtained all necessary antitrust and regulatory clearances. Roche will integrate LumiraDx’s innovative multi-assay point-of-care platform into its global organization, enhancing its diagnostics portfolio. The platform consolidates a wide range of immunoassay and clinical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
New Data Shed Light on Who Stops Using GLP-1 Drugs, and Why
STAT+: DeepSeek signals China’s rising influence in AI — and AI drug development
FDA Approves Third Tocilizumab Biosimilar
India targets to sequence 10 million genomes

Share This Article